Home › NDC Lookup › RxCUI directory › RxCUI 1006688

Sulfacetamide sodium 100 MG/ML Topical Lotion — RxCUI 1006688

RxNorm drug concept · Semantic clinical drug
RxCUI 1006688 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1006688
Official nameSulfacetamide sodium 100 MG/ML Topical Lotion
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known assulfacetamide sodium 10 % Topical Lotion; sulfacetamide sodium 10 % Topical Suspension
FDA products mapped3
Package NDCs mapped3
Reported Medicaid activity (SDUD)8,603 prescriptions · 23 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Sulfacetamide Ophthalmic: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It's an antibiotic drop that targets bacterial infections on the surface of your eye. The most common reason it's prescribed is conjunctivitis — what most people call pink eye — ca...
  • What is this eye drop actually treating?
  • At the start of treatment, you'll use them quite frequently — typically every two to three hours. As your eye starts to get better, your doctor will usually have you space the dose...
  • How often do I need to put the drops in?
📖 Read our full Sulfacetamide Ophthalmic guide →

🕸️ Concept Web — How Sulfacetamide sodium 100 MG/ML Topical Lotion Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Sulfacetamide sodium 100 MG/ML Topical Lotion RxCUI 1006688

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Sulfacetamide 10169
    • Sulfacetamide sodium 82101
  2. Brand names 2

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Carmol Scalp 284688
    • Klaron 217903
  3. Dose forms 12

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Sulfacetamide Topical Lotion 377819
    • Sulfacetamide sodium Topical Lotion 2648184
    • Sulfacetamide Topical Product 1162338
    • Sulfacetamide sodium Topical Product 2663047
    • Sulfacetamide Topical Lotion [Carmol Scalp] 636220
    • Sulfacetamide Topical Lotion [Klaron] 365766
    • Sulfacetamide sodium Topical Lotion [Carmol Scalp] 2657636
    • Sulfacetamide sodium Topical Lotion [Klaron] 2655151
    • +4 more in this family
  4. Clinical & branded drugs 5

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Sulfacetamide sodium 100 MG/ML 832863
    • Sulfacetamide sodium 100 MG/ML Topical Lotion [Carmol Scalp] 1006689
    • Sulfacetamide sodium 100 MG/ML Topical Lotion [Klaron] 1006693
    • Sulfacetamide sodium 100 MG/ML [Carmol Scalp] 904618
    • Sulfacetamide sodium 100 MG/ML [Klaron] 1006692
  5. Packs 2

    Fixed collections of drugs packaged and sold together, like dose packs.

    • {1 (85 ML) (sulfacetamide sodium 100 MG/ML Topical Lotion [Carmol Scalp]) / 1 (120 ML) (urea 100 MG/ML Medicated Shampoo [Carmol]) } Pack [Carmol Scalp Treatment Kit] 904620
    • {1 (85 ML) (sulfacetamide sodium 100 MG/ML Topical Lotion) / 1 (120 ML) (urea 100 MG/ML Medicated Shampoo) } Pack 904617

Showing up to 8 concepts per family — 19 of 23 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Sulfacetamide sodium 100 MG/ML SCDC · 832863
  • Sulfacetamide Topical Lotion SCDF · 377819
  • Sulfacetamide sodium Topical Lotion SCDFP · 2648184
  • Sulfacetamide Topical Product SCDG · 1162338
  • Sulfacetamide sodium Topical Product SCDGP · 2663047
  • {1 (85 ML) (sulfacetamide sodium 100 MG/ML Topical Lotion) / 1 (120 ML) (urea 100 MG/ML Medicated Shampoo) } Pack GPCK · 904617

Brand-Name Concepts

  • Sulfacetamide sodium 100 MG/ML Topical Lotion [Klaron] SBD · 1006693
  • Sulfacetamide sodium 100 MG/ML Topical Lotion [Carmol Scalp] SBD · 1006689
  • Sulfacetamide sodium 100 MG/ML [Carmol Scalp] SBDC · 904618
  • Sulfacetamide sodium 100 MG/ML [Klaron] SBDC · 1006692
  • Sulfacetamide Topical Lotion [Carmol Scalp] SBDF · 636220
  • Sulfacetamide Topical Lotion [Klaron] SBDF · 365766
  • Sulfacetamide sodium Topical Lotion [Carmol Scalp] SBDFP · 2657636
  • Sulfacetamide sodium Topical Lotion [Klaron] SBDFP · 2655151
  • Carmol Scalp Topical Product SBDG · 1175779
  • Klaron Topical Product SBDG · 1171413

📦 FDA Products & Package NDCs

3 products · 3 package NDCs
3 package NDCs map to RxCUI 1006688 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00187-5198-04 1 BOTTLE, PLASTIC in 1 CARTON (0187-5198-04) / 118 mL in 1... Klaron Bausch Health US, LLC 1996-12-23
45802-0896-26 118 mL in 1 BOTTLE, PLASTIC (45802-896-26) Sulfacetamide Sodium Padagis Israel Pharmaceuticals Ltd 2012-10-17
68682-0010-04 1 BOTTLE, PLASTIC in 1 CARTON (68682-010-04) / 118 mL in 1... Sodium sulfacetamide Oceanside Pharmaceuticals 2015-12-18
Observed labelers: Bausch Health US, LLC (1) · Oceanside Pharmaceuticals (1) · Padagis Israel Pharmaceuticals Ltd (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$0.5616
Range $0.5616–$0.5616 · middle 50% $0.5616–$0.5616 · 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.